Showing results (301-310 of 452) with videos related to

Sort By:
Pageof 46
British Journal of Cancer|March 29, 2000
Sigma-2 receptors as a biomarker of proliferation in solid tumoursK T Wheeler, L M Wang, C A Wallen, et al.
Nature Neuroscience|July 11, 2006
PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeysMichael A Nader, Drake Morgan, H Donald Gage, et al.
Bioorganic & Medicinal Chemistry|April 27, 2013
Evaluation of N-phenyl homopiperazine analogs as potential dopamine D3 receptor selective ligandsAixiao Li, Yogesh Mishra, Maninder Malik, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2015
Synthesis, pharmacological evaluation and molecular modeling studies of triazole containing dopamine D3 receptor ligandsXin Peng, Qi Wang, Yogesh Mishra, et al.
Pharmacology, Biochemistry, and Behavior|July 1, 1997
Use of positron emission tomography to study the dynamics of psychostimulant-induced dopamine releaseR H Mach, M A Nader, R L Ehrenkaufer, et al.
Bioorganic & Medicinal Chemistry Letters|February 28, 2018
Design, synthesis, and in vitro evaluation of quinolinyl analogues for α-synuclein aggregationXuyi Yue, Dhruva D Dhavale, Junfeng Li, et al.
Journal of Medicinal Chemistry|November 24, 2005
N-benzylisatin sulfonamide analogues as potent caspase-3 inhibitors: synthesis, in vitro activity, and molecular modeling studiesWenhua Chu, Jun Zhang, Chenbo Zeng, et al.
Nuclear Medicine and Biology|June 9, 2026
Evaluating the tumour detection efficacy of [18F]Fluorthanatrace positron emission tomography in a metastatic lung cancer animal modelChi-Chang Weng, Che-Hsing Chu, Faria Khan, et al.
Molecular Cancer|November 25, 2010
The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabineJohn R Hornick, Jinbin Xu, Suwanna Vangveravong, et al.
Pageof 46